OBJECTIVES: This study sought to evaluate the impact of sirolimus-eluting stent (SES) fractures on long-term clinical outcomes using multislice computed tomography (MSCT). METHODS: In this study, 528 patients undergoing 6- to 18-month follow-up 64-slice MSCT after SES implantation without early clinical events were followed clinically (the median follow-up interval was 4.6 years). A CT-detected stent fracture was defined as a complete gap with Hounsfield units (HU) <300 at the site of separation. The major adverse cardiac events (MACEs), including cardiac death, stent thrombosis, and target lesion revascularisation, were compared according to the presence of stent fracture. RESULTS: Stent fractures were observed in 39 patients (7.4 %). MACEs were more common in patients with CT-detected stent fractures than in those without (46 % vs. 7 %, p < 0.01). Univariate Cox regression analysis indicated a significant relationship between MACE and stent fracture [hazard ratio (HR) 7.65; p < 0.01], age (HR 1.03; p = 0.04), stent length (HR 1.03; p < 0.01), diabetes mellitus (HR 1.77; p = 0.04), and chronic total occlusion (HR 2.54; p = 0.01). In the multivariate model, stent fracture (HR 5.36; p < 0.01) and age (HR 1.03; p = 0.04) remained significant predictors of MACE. CONCLUSIONS: An SES fracture detected by MSCT without early clinical events was associated with long-term clinical adverse events. KEY POINTS: • Long-term outcomes of sirolimus-eluting stent fracture have not been fully clarified. • MSCT could detect stent fracture with high accuracy. • Sirolimus-eluting stent fracture detected by MSCT was associated with long-term adverse events.
OBJECTIVES: This study sought to evaluate the impact of sirolimus-eluting stent (SES) fractures on long-term clinical outcomes using multislice computed tomography (MSCT). METHODS: In this study, 528 patients undergoing 6- to 18-month follow-up 64-slice MSCT after SES implantation without early clinical events were followed clinically (the median follow-up interval was 4.6 years). A CT-detected stent fracture was defined as a complete gap with Hounsfield units (HU) <300 at the site of separation. The major adverse cardiac events (MACEs), including cardiac death, stent thrombosis, and target lesion revascularisation, were compared according to the presence of stent fracture. RESULTS: Stent fractures were observed in 39 patients (7.4 %). MACEs were more common in patients with CT-detected stent fractures than in those without (46 % vs. 7 %, p < 0.01). Univariate Cox regression analysis indicated a significant relationship between MACE and stent fracture [hazard ratio (HR) 7.65; p < 0.01], age (HR 1.03; p = 0.04), stent length (HR 1.03; p < 0.01), diabetes mellitus (HR 1.77; p = 0.04), and chronic total occlusion (HR 2.54; p = 0.01). In the multivariate model, stent fracture (HR 5.36; p < 0.01) and age (HR 1.03; p = 0.04) remained significant predictors of MACE. CONCLUSIONS: An SESfracture detected by MSCT without early clinical events was associated with long-term clinical adverse events. KEY POINTS: • Long-term outcomes of sirolimus-eluting stent fracture have not been fully clarified. • MSCT could detect stent fracture with high accuracy. • Sirolimus-eluting stent fracture detected by MSCT was associated with long-term adverse events.
Authors: Edward A Hulten; Salvatore Carbonaro; Sara P Petrillo; Joshua D Mitchell; Todd C Villines Journal: J Am Coll Cardiol Date: 2010-12-08 Impact factor: 24.094
Authors: Allen J Taylor; Manuel Cerqueira; John McB Hodgson; Daniel Mark; James Min; Patrick O'Gara; Geoffrey D Rubin; Christopher M Kramer; Daniel Berman; Alan Brown; Farooq A Chaudhry; Ricardo C Cury; Milind Y Desai; Andrew J Einstein; Antoinette S Gomes; Robert Harrington; Udo Hoffmann; Rahul Khare; John Lesser; Christopher McGann; Alan Rosenberg; Robert Schwartz; Marc Shelton; Gerald W Smetana; Sidney C Smith Journal: J Am Coll Cardiol Date: 2010-11-23 Impact factor: 24.094
Authors: Gaku Nakazawa; Aloke V Finn; Marc Vorpahl; Elena Ladich; Robert Kutys; Isidora Balazs; Frank D Kolodgie; Renu Virmani Journal: J Am Coll Cardiol Date: 2009-11-17 Impact factor: 24.094
Authors: Hiroshi Doi; Akiko Maehara; Gary S Mintz; Kenichi Tsujita; Takashi Kubo; Celia Castellanos; Jian Liu; Junqing Yang; Carlos Oviedo; Jiro Aoki; Theresa Franklin-Bond; Neil Dasgupta; Alexandra J Lansky; George D Dangas; Gregg W Stone; Jeffrey W Moses; Roxana Mehran; Martin B Leon Journal: Am J Cardiol Date: 2009-03-15 Impact factor: 2.778
Authors: F Pugliese; A C Weustink; C Van Mieghem; F Alberghina; M Otsuka; W B Meijboom; N van Pelt; N R Mollet; F Cademartiri; G P Krestin; M G M Hunink; P J de Feyter Journal: Heart Date: 2007-09-19 Impact factor: 5.994
Authors: Jeffrey J Popma; Klaus Tiroch; Alexandra Almonacid; Sidney Cohen; David E Kandzari; Martin B Leon Journal: Am J Cardiol Date: 2009-04-01 Impact factor: 2.778